Royalty Pharma RPRX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $618.7M-33.4% | $929.03M+94.8% | $477.01M-72.1% | $1.71B+11.0% | ||
| $18.8M-67.7% | $58.2M+218% | $18.3M+1,308% | $1.3M-98.0% | ||
| $20.46B+2,511% | $783.77M+6.1% | $738.44M+6.8% | $691.32M+12.5% | ||
| $1.53B-15.2% | $1.8B+41.4% | $1.27B-50.1% | $2.55B-11.2% | ||
| $924.63M— | $0— | —— | —— | ||
| $171.31M-8.4% | $186.96M-6.3% | $199.49M+77.6% | $112.35M-58.4% | ||
| $19.62B+7.7% | $18.22B+11.2% | $16.38B-2.6% | $16.81B-4.0% | ||
| $19.4M+45.1% | $13.37M-11.8% | $15.17M+91.8% | $7.91M+40.7% | ||
| $380M-61.9% | $997.77M— | $0-100% | $997.51M— | ||
| $636.21M-49.2% | $1.25B+677% | $161.38M-86.2% | $1.17B+581% | ||
| $8.57B+29.6% | $6.61B+7.8% | $6.14B+0.3% | $6.12B-13.8% | ||
| $9.91B+25.7% | $7.88B+25.1% | $6.3B-13.6% | $7.29B+0.3% | ||
| $2.36B-17.2% | $2.85B+13.0% | $2.52B+28.1% | $1.96B-12.9% | ||
| $9.71B-6.1% | $10.34B+2.6% | $10.08B+5.9% | $9.53B-7.1% | ||
| $19.62B+7.7% | $18.22B+11.2% | $16.38B-2.6% | $16.81B-4.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Royalty Pharma's total assets?
- Royalty Pharma (RPRX) holds $19.8B in total assets, up 12.5% year over year.
- How much debt does Royalty Pharma have?
- Royalty Pharma carries $9.0B in total debt against $9.9B of shareholders' equity, a debt-to-equity ratio of 0.90.
- How much cash does Royalty Pharma have?
- Royalty Pharma holds $586.4M in cash and equivalents.
- Can Royalty Pharma cover its short-term obligations?
- Its current ratio is 2.66 — current assets exceed current liabilities.
- Where does Royalty Pharma's balance sheet data come from?
- Every line is extracted from Royalty Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
